johnson & johnson news - Search News

Johnson & Johnson, Intra-Cellular

The Wall Street Journal on MSN · 46m

Johnson & Johnson to Acquire Intra-Cellular in $15 Billion Deal

Johnson & Johnson agreed to acquire mental-illness drug developer Intra-Cellular Therapies for about $15 billion.

Barron's on MSN · 1h

Johnson & Johnson in $14.6 Billion Deal to Buy Biotech Intra-Cellular

Johnson & Johnson has entered an agreement to acquire all outstanding shares of Intra-Cellular Therapies, in a multibillion-dollar bet on mental health therapies. Johnson & Johnson will pay $132 per share in cash for a total equity value of $14.

YAHOO!Finance · 1h

Johnson & Johnson Makes Biopharmaceutical Splash with $14.6B Intra-Cellular Deal

Johnson & Johnson just announced a major acquisition to boost its position in the biopharmaceutical market. The company today said it's buying Intra-Cellular Therapies, a company developing medicines for central nervous system (CNS) disorders, for $132 per share in cash, which represents a total equity value of approximately $14.6 billion.

Bears interview Lions assistants Ben Johnson, Aaron Glenn

CBS Chicago on MSN · 1d

Bears interview Lions offensive coordinator Ben Johnson and defensive coordinator Aaron Glenn for head coaching job

The Chicago Bears interviewed Detroit Lions offensive coordinator Ben Johnson and defensive coordinator Aaron Glenn for their head coach position on Saturday. Both Johnson and Glenn have been looked at as top candidates this cycle,

Fox Sports · 1d

Bears interview Lions assistants Ben Johnson, Aaron Glenn for head coaching position

The Chicago Bears have interviewed Detroit Lions offensive coordinator Ben Johnson and defensive coordinator Aaron Glenn for their head coaching position

Reuters on MSN · 1d

Lions OC Ben Johnson talks to Bears about head coach job

Detroit Lions offensive coordinator Ben Johnson, one of the hottest candidates on the 2025 head coaching circuit, interviewed for the Chicago Bears' top job, the team announced Saturday. Johnson, 38,

4hon MSN

Johnson & Johnson makes $15 billion bet on mental-health drugs

Pharma giant Johnson & Johnson is buying Intra-Cellular Therapies, eying sales growth above analysts’ expectations through ...

2d

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Johnson & Johnson (JNJ) And Encourages Investors to Reach Out

NEW YORK, NY / ACCESSWIRE / January 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf ...

2d

Johnson & Johnson Could Serve As High-Yield Bond Alternative

Johnson & Johnson remains a Buy for its stability and consistent dividends, despite short-term price fluctuations and modest ...

2don MSN

Johnson & Johnson stock outperforms competitors despite losses on the day

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Johnson & Johnson MedTech halts Varipulse PFA cases due to stroke reports

Johnson & Johnson MedTech has temporarily paused all U.S. external evaluations and cases using its Varipulse pulse field ...

4d

Cautious Outlook on Johnson & Johnson Amid Currency and Legal Challenges

Wells Fargo analyst Larry Biegelsen maintained a Hold rating on Johnson & Johnson (JNJ – Research Report) yesterday and set a price target ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results